Facebook Linkedin RSS Twitter Youtube
Home 2021

Business ethic

Pressure Builds to Elevate Continuous Bioprocessing
Bioprocessing

Pressure Builds to Elevate Continuous Bioprocessing

Business Case for Continuous Processes Should Consider Platforms
Bioprocessing

Business Case for Continuous Processes Should Consider Platforms

CLOSE TO THE EDGE: <br>Exclusive Live Interviews with Biotech Executives from GEN EDGEExclusive Live Interviews with Biotech Executives from GEN EDGE />
GEN Edge

CLOSE TO THE EDGE:
Exclusive Live Interviews with Biotech Executives from GEN EDGE

New Sartorius Downstream U.K. Hub Can Host On-Site and Virtual Tech Tests
Bioprocessing

New Sartorius Downstream U.K. Hub Can Host On-Site and Virtual Tech Tests

“GEN Edge Live” Offers Timely, Topical Business Slant on Biopharma
GEN Edge

“GEN Edge Live” Offers Timely, Topical Business Slant on Biopharma

Recipharm Signs Manufacturing Agreement with Sweden’s Enzymatica
Bioprocessing

Recipharm Signs Manufacturing Agreement with Sweden’s Enzymatica

CCRM Helping to Solve the Big Problems in Regenerative Medicine
Sponsored

CCRM Helping to Solve the Big Problems in Regenerative Medicine

Sumitomo Dainippon Commits $3B toward Alliance with Roivant
Drug Discovery

Sumitomo Dainippon Commits $3B toward Alliance with Roivant

Brexit Concerns Draw Some U.K. Businesses to Ireland
GEN Edge

Brexit Concerns Draw Some U.K. Businesses to Ireland

In Deals with Envigo, LabCorp to Expand Covance’s Nonclinical Drug Development Capabilities
Drug Discovery

In Deals with Envigo, LabCorp to Expand Covance’s Nonclinical Drug Development Capabilities

123...14Page 1 of 14
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.